When: Confirmed close >$280 with volume

Then: Deploy remaining capacity on $280 breakout confirmation

HOLD

• ATR of 8.68 indicates volatility compression, not directional setup; can resolve in either direction with equal force
• Q2 2026 CapEx of $514M is not an annualized run-rate; major fab construction is winding down and CapEx could snap back to $4 billion annually if industrial demand softens
• The $8.8 billion annualized FCF figure is a marketing narrative, not a risk-adjusted base case
• Declining 50 SMA at $277 represents overhead supply from underwater institutional holders; creates incentive to sell into rallies
• Forward P/E of 25.2 is at top of TXN's historical range; higher-for-longer regime could compress multiples 10-15% to 225-230 with zero fundamental change
• A $258 stop near the September 3 swing low at $248 gets hunted; proper stop is either trailing 1.5 ATR (~$256) or structural stop at $248
• Beta 1.31 means a one-day move of $9 to $13 is within normal ATR distribution; gaps through the 50 SMA are plausible on macro shocks
• Single Zacks headline about TXN price hikes does not constitute structural re-rating; competitive landscape (MCHP open-standard connectivity) is intensifying
• Performance anxiety ("underperforming benchmark 15-20%") is performance chasing, not investing; capital preservation through cycles is the job of risk management

→ vs aggressive: Volatility compression (ATR 8.68) is neutral, not bullish; the "coiled spring" narrative ignores equally plausible downside expansion that gaps through the 50 SMA in a single session

→ vs aggressive: ASP catalyst from single Zacks headline is insufficient; competitive landscape is intensifying (MCHP open-standard connectivity competing with TXN analog auto book), and actual cycle position won't be confirmed until late October earnings

→ vs aggressive: FCF doubling thesis is flawed: $514M quarterly CapEx is not annualized, and extrapolating it ignores that TXN historically accelerates CapEx during upcycles to capture share

→ vs aggressive: 50 SMA at $277 being called irrelevant is trend-confirmation bias; declining SMA means average holder from past 50 days is underwater and represents overhead supply

→ vs aggressive: Macro dismissal is uncompensated risk; 93% no-cut odds and rate-hike regime compress multiples at 25.2 forward P/E regardless of earnings growth

→ vs aggressive: $258 stop is near swing low where stock has already capitulated; stops at obvious technical levels get hunted; "tight stop, big size" is margin-call discipline, not risk management

→ vs aggressive: $235-240 zone dismissal ignores genuine asymmetric upside (28% return to current prices with stop at $232 against SMA); "betting on macro shocks" framing mischaracterizes normal probability pullback expectation

→ vs aggressive: Performance anxiety argument ("questioned for underperforming benchmark 15-20%") is explicit performance chasing and violates fiduciary capital preservation obligations

HOLD current position at neutral-relative-to-benchmark sizing with specific refinements: small starter add on confirmed close above $272 (25% of planned add), maintain $258 stop, preserve $235-240 add zone, do not trim on bounce, consider covered call at $280 strike for October expiry, reassess after Q3 print

• Technical setup has improved (MACD positive, RSI reclaimed 50, price above 10 EMA, ATR compressed) but medium-term structure is concerning with 50 SMA at $277 declining
• 50 SMA decline reflects overhead supply from institutional buyers accumulated between $280-$310 in July who will sell into rallies
• ASP price hike catalyst is a data point requiring Q3 confirmation before declaring regime change
• Q2 2026 CapEx of $514M is tail end of major fab construction cycle, not steady-state; annualized $8.8B FCF is marketing narrative
• Volatility compression is neutral, not inherently bullish or bearish
• Macro backdrop (93% no-cut odds, rate-hike regime) presents real multiple compression risk but tail case should not be priced as base case
• $235-240 is the only high-conviction add zone for fresh capital deployment
• $258 stop is appropriate balance; widening to $248 gives back too much, tightening below $256 exposes to noise
• Do NOT trim 15-25% on this bounce - selling at first meaningful technical reversal after 24% drawdown is poor practice
• Covered call at $280 strike for October expiry generates income without paying premium, more balanced than put hedge
• With 1.31 beta in rate-hike regime, position sizing at neutral-relative-to-benchmark is appropriate
• Reassess after Q3 print in late October based on whether ASP gains are sticking and 50 SMA trajectory

→ vs aggressive: Treating short-term technical setup as complete picture while dismissing medium-term structure; 50 SMA lag reflects actual participant behavior not an error; ASP catalyst requires Q3 confirmation before declaring regime change; FCF doubling extrapolates from fab construction tail-end CapEx that snaps back to $3-4B in upcycles; underperformance anxiety argument signals loss of fundamental justification

→ vs conservative: Using neutral ATR compression as justification for trimming doesn't follow; neutrality means no high-conviction direction, not selling into constructive reversal; macro pricing tail case as base case when Polymarket shows no-cuts odds not hike pricing; $248 stop gives back 7-8% equivalent to not trusting position at all; $235-240 add zone correct but put hedge is overkill on borderline risk; trimming 15-25% on first meaningful bounce after capitulation is selling at worst time